The clinical, morphological and immunohistochemical features of this lesion are consistent with those reported in the literature, but to the best of our knowledge, this is the first description of a novel NUMA1::NTRK1 fusion in an NTRK-rearranged uterine sarcoma or any other tumour type. This evidence concerns the gene NTRK1 and uterine corpus sarcoma.